[纤维肌痛病理学的肌肉组成]
Daniel Yechiali1, Liel Katbi1, Gilad Halpert1
1Department of Medicine 'B', Zabludowicz Center for Autoimmune Diseases, The Arrow Program, Sheba Medical Center, Israel; Sackler Faculty of Medicine, Tel-Aviv University Tel-Aviv, Israel Arrow Program for Medical Research Education Sheba Medical Center, Tel Hashomer, Israel.
Harefuah
|June 17, 2024
概括
纤维肌痛综合征 (FMS) 涉及慢性疼痛,疲劳和虚弱,主要影响女性. 本综述探讨了肌肉骨和中枢神经系统 (CNS) 功能障碍如何导致FMS.
科学领域:
- 类风湿病学 类风湿病学
- 神经科学是一个神经科学.
- 肌肉骨医学 肌肉骨医学
背景情况:
- 纤维肌痛综合征 (FMS) 是一种慢性疼痛状况,其特征是广泛的肌肉骨疼痛,疲劳和虚弱.
- FMS对女性的影响不成比例,其潜在的病理生理机制仍然不完全理解.
- 目前的理解涉及多种致病理论,突出了全面审查的必要性.
研究的目的:
- 审查最近关于肌肉骨功能障碍对纤维肌痛综合征 (FMS) 影响的文献.
- 研究FMS中肌肉骨系统和中枢神经系统 (CNS) 之间的相互作用.
- 综合当前关于这些系统中乱在FMS病变发生中的作用的知识.
主要方法:
- 系统审查近年出版的文章.
- 专注于检查肌肉骨系统功能障碍与FMS相关的研究.
- 对FMS患者中中枢神经系统 (CNS) 乱的研究进行分析.
主要成果:
- 最近的研究强调了肌肉骨功能障碍和FMS症状之间的重要联系.
- 有证据表明,中枢神经系统 (CNS) 的改变在FMS病理生理学中起着至关重要的作用.
- 该审查综合了关于FMS中外围和中心机制之间的复杂相互作用的发现.
结论:
- 肌肉骨功能障碍是导致纤维肌痛综合征 (FMS) 的关键因素.
- 中枢神经系统 (CNS) 疾病是FMS的发展和维持不可或缺的一部分.
- 进一步研究这些相互连接的系统对于有效的FMS管理至关重要.
相关概念视频
Layers of Connective Tissue Proper
1.9K
Fascia, a thin layer of fibrous connective tissue, is distributed throughout the body. It demarcates and forms a supportive covering over skeletal muscles, bones, blood vessels, and organs. There are three main types of facia— superficial fascia, deep fascia, and subserous fascia. These are all present at different depths in the body. Fascia reduces the friction and permits muscles, joints, and organs to easily slide against each other, facilitating movement of the body and preventing...
1.9K
Disorders of the Skeletal Muscle
928
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
928
Relaxation of Skeletal Muscles
3.2K
The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open....
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open....
3.2K
Chemical Synapses
8.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.8K
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Myasthenia Gravis: Diagnostic Tests
764
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
764


